Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pegylated recombinant anti-Pseudomonas aeruginosa PcrV Fab' antibody

EU orphan designation number: EU/3/13/1178   
Active ingredient: Pegylated recombinant anti-Pseudomonas aeruginosa PcrV Fab' antibody
Indication: Treatment of Pseudomonas aeruginosa lung infection in cystic fibrosis
Sponsor: KaloBios Ltd
5 Fleet Place, London EC4M 7RD, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/08/2013 Centralised Orphan - Designation EMA/OD/073/13 (2013)5277 of 05/08/2013